Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-08

Clinical Trial Update: Safety and Efficacy of Zicronapine in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the safety and efficacy of Zicronapine in patients with schizophrenia and is completed. The available excerpt does not include the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zicronapine

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED